New Jersey-based Admera Health LLC is set to pay a hefty sum in a settlement after allegations surfaced that the company was involved in kickback schemes to boost their laboratory testing referrals, a violation of federal law that aims to ensure medical practitioners prioritize patient health over profits. According to a release from the U.S. Attorney's Office, health company has consented to pay over $5 million to the United States, as well as an additional amount to individual states affected.
"By entering into kickback arrangements, health care companies can cause providers to make medical decisions that are motivated by financial gain rather than the patient’s best interest," U.S. Attorney Phillip A. Talbert elaborated, demonstrating a concern that such unethical behavior distorts the sanctity of the doctor-patient relationship and compromises the quality of medical care, detailing how Admera's practices specifically led the company and their independent contractor marketers, through commission-based payments, to entangle themselves in actions that federal statutes prohibit, thereby undermining the proper administration of Medicare and Medicaid funded services, as mentioned by the U.S. Attorney's Office.
It was made clear that from Sept. 1, 2014, to May 21, 2021, Admera paid contractors commissions that depended on the volume and value of the genetic testing referrals they secured, a practice that has been identified as against the Anti-Kickback Statute; these payments were ostensibly made in exchange for their recommendation or facilitation of orders for laboratory services, including genetic tests covered by federally funded programs.
The resolution incorporates settling claims initiated under the qui tam or whistleblower provisions of the False Claims Act by Sunil Wadhwa and Ken Newton, who are co-founders of Financial Halo LLC/MedXPrime and were former third-party marketers for Admera; they will receive a $862,343 slice of the settlement, a reward for their part in unearthing the questionable dealings that have brought into focus on the urgent need to address the pervasive culture of kickbacks within the health care sector.
Further emphasizing the gravity of the situation, and underscoring the legal stance against such fraudulence, "The Department is committed to holding accountable those who engage in kickback arrangements that undermine the integrity of federal healthcare programs," said Principal Deputy Assistant Attorney General Brian M. Boynton; this settlement is another example of governmental bodies working collectively to clamp down on the corruption that can taint healthcare practices and potentially harm both patients and the trust they place in their providers, as reported by the U.S. Attorney's Office.
While the allegations have been resolved monetarily, Admera Health has not been found legally liable as part of this settlement; however, the case highlights a continued government focus on combating health care fraud, suggesting that the ramifications for such actions are becoming ever more significant – not only financially, but in terms of the reputations of those found at the crossroads of profit and patient care. Individuals with information about fraud or abuse related to health are encouraged to report it to the Department of Health and Human Services.
